Show Notes
N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for cancer and vaccine treatments using its unique silica nanoparticle delivery system called Nuvec®.
We spoke with Nigel today and asked about the progress the company is making and shareholders question.
N4 Pharma's business model is to partner with companies developing novel antigens for cancer and vaccine treatments to use Nuvec® as the delivery vehicle to get their antigen into cells to express the protein needed for the required immunity. As these products progress through pre-clinical and clinical programs, N4 Pharma will seek to receive upfront payments, milestone payments and ultimately royalty payments once products reach the market.
https://www.share-talk.com/nigel-theobald-ceo-of-n4-pharma-plc-n4p-l-interview/
https://www.share-talk.com/nigel-theobald-ceo-of-n4-pharma-plc-n4p-l-interview/
Listen On
Also Listen
-
Zak Mir spoke with Australian Gold and Copper Ltd (ASX:AGC) MD Glen Diemar on today’s Achilles results
Achilles Northern Zone Delivers Exceptional Grades AGC Managing Director, Glen -
Zak Mir talks to Alexander Selegenev, Executive Director, TMT Investments
Zak Mir talks to Alexander Selegenev, Executive Director, TMT Investments, after -
Zak Mir interviews Poolbeg Pharma’s CEO Jeremy Skillington & Principal Scientist Liam Tremble
Poolbeg Pharma PLC (AIM: POLB, OTC: POLBF) Chief Executive Officer Jeremy Skill -
Zak Mir talks to Paul Mathieson, CEO of Amazing AI Plc
Zak Mir talks to Paul Mathieson, CEO of Amazing AI, in the wake of the global fi